ClinVar Miner

Submissions for variant NM_033360.4(KRAS):c.64C>A (p.Gln22Lys)

dbSNP: rs121913236
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Baylor-Hopkins Center for Mendelian Genomics, Johns Hopkins University School of Medicine RCV001078206 SCV001244302 likely pathogenic Linear nevus sebaceous syndrome criteria provided, single submitter research
Labcorp Genetics (formerly Invitae), Labcorp RCV005090693 SCV005807099 likely pathogenic RASopathy 2024-11-27 criteria provided, single submitter clinical testing This sequence change replaces glutamine, which is neutral and polar, with lysine, which is basic and polar, at codon 22 of the KRAS protein (p.Gln22Lys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with port wine stain, veno-capillary malformation (PMID: 30677207). ClinVar contains an entry for this variant (Variation ID: 376325). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt KRAS protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects KRAS function (PMID: 31160609, 34117033). This variant disrupts the p.Gln22 amino acid residue in KRAS. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17056636, 17324647, 29948256; internal data). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.